Inventor
QIAN WENYUAN
US42 patents
⚠️ This page may combine multiple inventors who share the name “QIAN WENYUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN INC
16 patentsUS9611261B2Apr 4, 2017
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC25 citations94
US9085576B2Jul 21, 2015
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC31 citations94
US7538114B2May 26, 2009
Glycine transporter-1 inhibitors
AMGEN INC14 citations91
US9303028B2Apr 5, 2016
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC4 citations84
US9174992B2Nov 3, 2015
Heterobicyclic compounds
AMGEN INC4 citations72
US8691986B2Apr 8, 2014
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC3 citations63
US9296734B2Mar 29, 2016
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC2 citations62
US7425631B2Sep 16, 2008
Compounds and methods of use
AMGEN INC2 citations62
US7393852B2Jul 1, 2008
Piperazine derivatives and methods of use
AMGEN INC3 citations60
US11021493B2Jun 1, 2021
1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
AMGEN INC0 citations52
US9493459B2Nov 15, 2016
Azetidine and piperidine compounds useful as PDE10 inhibitors
AMGEN INC0 citations52
US9550762B2Jan 24, 2017
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC1 citations51
US7662811B2Feb 16, 2010
1,2,3,4-tetrahydropyrazin-2-yl acetamides and methods of use
AMGEN INC1 citations51
US9663476B2May 30, 2017
Glycine transporter-1 inhibitors
AMGEN INC0 citations50
US10246429B2Apr 2, 2019
Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use
AMGEN INC0 citations41
US7612060B2Nov 3, 2009
Triazoles and methods of use
AMGEN INC0 citations41
MEDSHINE DISCOVERY INC
6 patentsUS11384065B2Jul 12, 2022
Heterocyclic compound as CSF-1R inhibitor and use thereof
MEDSHINE DISCOVERY INC0 citations51
US11299475B2Apr 12, 2022
Prostacyclin receptor agonist
MEDSHINE DISCOVERY INC0 citations51
US11230544B1Jan 25, 2022
Substituted 1,3,4-thiadiazoles as GLS1 inhibitors
MEDSHINE DISCOVERY INC0 citations50
US11230549B2Jan 25, 2022
Quinolino-pyrrolidin-2-one derivative and application thereof
MEDSHINE DISCOVERY INC0 citations50
US11634424B2Apr 25, 2023
Diazaindole derivative and use thereof as CHK1 inhibitor
MEDSHINE DISCOVERY INC0 citations49
US10508103B2Dec 17, 2019
Benzimidazole-linked indole compound acting as novel divalent IAP antagonist
MEDSHINE DISCOVERY INC0 citations41
WUXI BIOCITY BIOPHARMACEUTICS CO LTD
5 patentsUS11434232B2Sep 6, 2022
ATR inhibitor and application thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD2 citations72
US11613545B2Mar 28, 2023
Macrocyclic compound serving as Wee1 inhibitor and applications thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD2 citations71
US12479839B2Nov 25, 2025
Crystalline form of ATR inhibitor and use thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD0 citations61
US12291536B2May 6, 2025
Crystal form of Wee1 inhibitor compound and use thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD0 citations50
US12180184B2Dec 31, 2024
Pyrimidopyrazolone derivative as Wee1 inhibitor and use thereof
WUXI BIOCITY BIOPHARMACEUTICS CO LTD0 citations50